InnovAge Holding Corp
NASDAQ:INNV

Watchlist Manager
InnovAge Holding Corp Logo
InnovAge Holding Corp
NASDAQ:INNV
Watchlist
Price: 5.03 USD -2.33% Market Closed
Market Cap: 682.5m USD

InnovAge Holding Corp
Investor Relations

InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. The company is headquartered in Denver, Colorado and currently employs 1,800 full-time employees. The company went IPO on 2021-03-04. The firm delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors, and it serve participants primarily through Program of All-inclusive Care for the Elderly (PACE). InnovAge Platform provides complete, coordinated healthcare to enable its frail, nursing home-eligible seniors to live independently in their homes and communities. The InnovAge Platform consists of Interdisciplinary Care Teams and community-based care delivery model. The firm's subsidiaries include TCO Intermediate Holdings, Inc., Total Community Options, Inc., InnovAge Investment Holdings, LLC, TCO Eastern Holdings, LLC, InnovAge Pennsylvania LIFE, LLC, InnovAge Virginia PACE Roanoke Valley, LLC, InnovAge Virginia PACE II, LLC, InnovAge Virginia PACE Charlottesville, LLC, Total Longterm Care Solutions, LLC, Total Longterm Care, Inc. and InnovAge Greater Colorado PACE-Loveland, LLC.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Nov 4, 2025
AI Summary
Q1 2026

Revenue Growth: InnovAge reported Q1 revenue of $236.1 million, up 15% year-over-year and 6.6% sequentially, driven by higher member months and capitation rates.

Census Record: Participant census reached an all-time high of 7,890, up 1.9% sequentially and 9.4% year-over-year.

Profitability Milestone: Net income was $7.7 million, marking the first positive net income since 2021, and adjusted EBITDA more than doubled compared to last year.

Margin Expansion: Center-level contribution margin rose to 21.8% of revenue, up 320 basis points from the prior quarter.

Cost Control: Total participant expense per month declined sequentially, with lower skilled nursing utilization and pharmacy costs helping to offset wage inflation.

Guidance Reaffirmed: Management reaffirmed 2026 guidance for revenue ($900–950 million), adjusted EBITDA ($56–65 million), and year-end census (7,900–8,100).

Operational Progress: Leadership transitions, organizational streamlining, and continued investment in clinical and IT infrastructure were highlighted as key enablers of momentum.

Competitive Position: Management noted resilience of the PACE model versus pressures in Medicare Advantage and Medicaid, emphasizing InnovAge's operating advantages and differentiation.

Key Financials
Revenue
$236.1 million
Participant Census
7,890
Member Months
23,500
Center-Level Contribution Margin
$51.4 million
Center-Level Contribution Margin (%)
21.8%
Adjusted EBITDA
$17.6 million
Adjusted EBITDA Margin
7.5%
Net Income
$7.7 million
Net Income Per Share
$0.06
Sales and Marketing Expense
$7.6 million
Corporate, General and Administrative Expense
$30.3 million
External Provider Costs
$108.9 million
Cost of Care (excluding D&A)
$75.9 million
De Novo Center Losses
$3.9 million
Cash and Equivalents
$67.1 million
Short-Term Investments
$42.3 million
Total Debt
$71.5 million
Cash Flow from Operations
$3.9 million
Capital Expenditures
$4.1 million
Participant Satisfaction
90%
Participants Would Choose InnovAge Over Nursing Home
97%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Patrick Blair
Chief Executive Officer
No Bio Available
Mr. Benjamin Crowninshield Adams
Chief Financial Officer
No Bio Available
Ms. Nicole D'Amato
Chief Legal Officer & Corporate Secretary
No Bio Available
Hon. Marilyn Barbour Tavenner M.H.A., R.N.
Independent Director
No Bio Available
Mr. Michael Scarbrough
President & COO
No Bio Available
Ms. Cara Babachicos
Chief Information Officer
No Bio Available
Mr. Ryan Kubota
Director of Investor Relations
No Bio Available
Ms. Olivia Patton
Chief Compliance Officer
No Bio Available
Mr. Matt Huray
Chief Strategy & Corporate Development Officer
No Bio Available

Contacts

Address
COLORADO
Denver
8950 E. Lowry Boulevard
Contacts
+13038694664.0
www.innovage.com